Cargando…
Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology
Clearance of viral infections, such as SARS-CoV-2 and influenza A virus (IAV), must be fine-tuned to eliminate the pathogen without causing immunopathology. As such, an aggressive initial innate immune response favors the host in contrast to a detrimental prolonged inflammation. The complement pathw...
Autores principales: | Santos, Nuno Brito, Vaz da Silva, Zoé Enderlin, Gomes, Catarina, Reis, Celso A., Amorim, Maria João |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248730/ https://www.ncbi.nlm.nih.gov/pubmed/34197564 http://dx.doi.org/10.1371/journal.ppat.1009381 |
Ejemplares similares
-
Inhibiting influenza's immunopathology
por: Moy, Brian
Publicado: (2009) -
ER stress induced immunopathology involving complement in CADASIL: implications for therapeutics
por: Panahi, Mahmod, et al.
Publicado: (2023) -
Complement Factor C7 Contributes to Lung Immunopathology Caused by Mycobacterium tuberculosis
por: Welsh, Kerry J., et al.
Publicado: (2012) -
Immunopathological Aspects of Experimental Trypanosoma cruzi Reinfections
por: Reis Machado, Juliana, et al.
Publicado: (2014) -
Immunopathology of terminal complement activation and complement C5 blockade creating a pro‐survival and organ‐protective phenotype in trauma
por: Yang, Zhangsheng, et al.
Publicado: (2022)